All Stories

  1. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study
  2. Predicting Chronic Spontaneous Urticaria Symptom Return After Omalizumab Treatment Discontinuation: Exploratory Analysis
  3. Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe
  4. Biologics in chronic urticaria
  5. Oral immunotherapy using polymeric nanoparticles loaded with peanut proteins in a murine model of fatal anaphylaxis
  6. Improvement of the Elevated Tryptase Criterion to Discriminate IgE- From Non–IgE-Mediated Allergic Reactions
  7. Adjuvants for allergy immunotherapeutics
  8. Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells
  9. Angio-oedema without hives, IgE and omalizumab
  10. Allergy rhinitis: similarities and differences between children and adults
  11. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion
  12. Induction of tolerance to different types of fish through desensitization with hake
  13. Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis
  14. Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements
  15. Allergic rhinitis causes loss of smell in children: The OLFAPEDRIAL study
  16. Pros and Cons of Clinical Basophil Testing (BAT)
  17. Valoración de tutores clínicos y estudiantes de medicina respecto a las rotaciones en centros de atención primaria y hospitales
  18. Technical flaws in multiple-choice questions in the access exam to medical specialties (“examen MIR”) in Spain (2009–2013)
  19. Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria
  20. Comparable actions of omalizumab on mast cells and basophils
  21. The Incidence of Perioperative Sensitivity Reactions
  22. Validation of The Spanish Version of The Urticaria Activity Score (Uas) and Its Use Over One Week (Uas7)
  23. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease
  24. Immunological events in chronic spontaneous urticaria
  25. Profile of omalizumab in the treatment of chronic spontaneous urticaria
  26. The Incidence of Perioperative Hypersensitivity Reactions
  27. Are all new allergens in TRUE Test®essential for a baseline set?
  28. Positive response to omalizumab in patients with acquired idiopathic nonhistaminergic angioedema
  29. Management of urticaria: not too complicated, not too simple
  30. Identification and Characterization of a New Oil Body Fraction Peanut Allergen
  31. Satisfacción de los estudiantes ante una sesión de exploración cardiológica impartida por compañeros entrenados
  32. Management of angioedema without urticaria in the emergency department
  33. Nanoparticle based-immunotherapy against allergy
  34. Immunogenicity of Peanut Proteins Containing Poly(Anhydride) Nanoparticles
  35. Perioperative Reactions: Are They So Infrequent?
  36. The usefulness of plasma histamine and different tryptase cut-off points in the diagnosis of peranaesthetic hypersensitivity reactions
  37. Pomegranate (Punica granatum L.) Expresses Several nsLTP Isoforms Characterized by Different Immunoglobulin E-Binding Properties
  38. Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain
  39. A Randomized Trial of Cardiopulmonary Resuscitation Training for Medical Students
  40. Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice
  41. Bilastine for the treatment of urticaria
  42. Analysis of the Association Between Food Allergy and Sensitization to Ltp and Profilin
  43. The Absence of Oil Body Proteins in Allergenic Extract Might Be Involved in False-Negative Diagnosis of Some Peanut Allergic Patients
  44. Pru p 3 acts as a strong sensitizer for peanut allergy in Spain
  45. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria
  46. Development of poly(anhydride) nanoparticles loaded with peanut proteins: The influence of preparation method on the immunogenic properties
  47. Validation of the modified allergic rhinitis and its impact on asthma (ARIA) severity classification in allergic rhinitis children: the PEDRIAL study
  48. Nanoparticulate Adjuvants and Delivery Systems for Allergen Immunotherapy
  49. Can component-based microarray replace fluorescent enzimoimmunoassay in the diagnosis of grass and cypress pollen allergy?
  50. Pharmacokinetic evaluation of levocetirizine
  51. Omalizumab is effective in nonautoimmune urticaria
  52. Ara H 9 Is The Main Allergen In Peanut Allergic Patients In The Mediterranean Area Regardless The Symptom Severity
  53. Diagnostic Reliability Of The Component-based Allergen-microarray In Grass, Cypress And Olive Pollens Allergy
  54. Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: The PEDRIAL study
  55. Creating Biomimetic Polymeric Surfaces by Photochemical Attachment and Patterning of Dextran
  56. Serum total tryptase levels are increased in patients with active chronic urticaria
  57. Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients - The ADRIAL cohort study
  58. Differences In The Immunologic Response To Peanut Allergen Depending Upon The Route, Lipid Content And Peanut Roasting In An Animal Model
  59. In vitro Diagnosis of Anaphylaxis
  60. Evaluation of Treatment Satisfaction in Children with Allergic Disease Treated with an Antihistamine
  61. A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne
  62. Adult onset Still's disease after first cycle of pemetrexed and gemcitabine for non-small cell lung cancer
  63. Chronic urticaria: do urticaria nonexperts implement treatment guidelines? A survey of adherence to published guidelines by nonexperts
  64. Toxic Epidermal Necrolysis Related to Pemetrexed and Carboplatin with Vitamin B12 and Folic Acid Supplementation for Advanced Non-Small Cell Lung Cancer
  65. Allergen immunotherapy with nanoparticles containing lipopolysaccharide from Brucella ovis
  66. Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy)
  67. Molecular Diagnosis by Microarray Technology in Polysensitized Atopic Patients
  68. Gantrez® AN nanoparticles as an adjuvant for oral immunotherapy with allergens
  69. Chronic urticaria: What is new, where are we headed
  70. Intradermal immunization with ovalbumin-loaded poly-?-caprolactone microparticles conferred protection in ovalbumin-sensitized allergic mice
  71. Progress and Challenges in the Understanding of Chronic Urticaria
  72. Progress and Challenges in the Understanding of Chronic Urticaria
  73. Usefulness Of Specific Ige Determination To Recombinant Grass Pollen Allergens (cap-feia) In Pollinic Patients
  74. Development of a Novel Vaccine Delivery System Based on Gantrez Nanoparticles
  75. Study of the Role of Basophils in Skin Biopsies of Urticaria
  76. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli
  77. Gantrez® AN nanoparticles do not alter allergenicity of Lollium extract
  78. Comments regarding 'Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells' by Asero et al. M. Ferrer
  79. Urticaria crónica: estudio etiológico prospectivo e importancia del síndrome autoinmune
  80. IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera
  81. Siberian hamster: a new indoor source of allergic sensitization and respiratory disease
  82. Secretion of Cytokines, Histamine and Leukotrienes in Chronic Urticaria
  83. Intracellular cytokine IL4 and INF-gamma production in lymphocytes from patients with chronic urticaria
  84. Amiodarone-induced angioedema
  85. Complement dependence of histamine release in chronic urticaria☆☆☆
  86. Importance of food allergy in atopic dermatitis
  87. In vitro antigen‐specific sulphidoleukotriene production in patients allergic to Dermatophagoides pteronyssinus
  88. Comparative studies of functional and binding assays for IgG anti-FcϵRIα (α-subunit) in chronic urticaria☆☆☆★★★
  89. Sulphidoleukotriene and Histamine Releasability in Atopic Patients
  90. 406 Sulphidoleukotriene releasability in pollinic patients
  91. Specific Immunotherapy Induces Changes in Spontaneous IgE Synthesis